Segment information has been adjusted to exclude impairment and amortisation of acquired intellectual property (IP) and non-recurring items resulting from business acquisition and disposals. NPATA represents the statutory net profit after tax before impairment and amortisation of acquired IP and non-recurring items resulting from business acquisitions and disposals (as referenced above). Refer to the next page for the reconciliation between the segment information and statutory results. CSL Behring CSL Seqirus CSL Vifor Consolidated Entity US$m 2025 2024 2025 2024 2025 2024 2025 2024 Sales and service revenue 10,930 10,334 1,906 1,896 2,199 2,029 15,035 14,259 Influenza pandemic facility reservation fees — — 179 172 — — 179 172 Royalty and license revenue 190 235 — — 26 24 216 259 Other income 38 39 81 60 9 11 128 110 Total segment revenue 11,158 10,608 2,166 2,128 2,234 2,064 15,558 14,800 Segment gross profit 5,641 5,275 1,257 1,318 1,545 1,413 8,443 8,006 Segment gross profit % 50.6% 49.7% 58.0% 61.9% 69.2% 68.5 % 54.3% 54.1% Selling and marketing expenses (937) (903) (230) (196) (449) (457) (1,616) (1,556) Segment operating result 4,704 4,372 1,027 1,122 1,096 956 6,827 6,450 Segment operating result % 42.2% 41.2% 47.4% 52.7% 49.1% 46.3 % 43.9% 43.6% Research and development expenses (1,359) (1,428) General and administrative expenses (1,000) (825) Underlying EBIT 4,468 4,197 Finance costs (448) (476) Finance income 38 39 Profit before tax 4,058 3,760 Income tax expense (645) (722) NPATA 3,413 3,038 - Attributable to CSL shareholders 3,219 2,907 - Attributable to non-controlling interests 194 131 Underlying EBIT 4,468 4,197 Non-recurring items related to CSL Vifor acquisition — (84) Net gain on business disposals 30 — Amortisation of other intangibles (excluding acquired IP)1 5 5 20 16 7 7 104 109 Depreciation1 335 337 59 60 23 25 549 528 EBITDA2 5,044 4,714 1,106 1,198 1,126 988 5,151 4,750 97 1 Depreciation and amortisation expenses (excluding IP) of $204m (2024: $187m) relate to non-segment expenditure and are not allocated to segments. 2 The Group's EBITDA of $5,151m (2024: $4,750m) represents statutory operating profit (EBIT) of $4,134m (2024: $3,812m) as reported in the consolidated income statement adding back total depreciation and amortisation expense of $1,017m (2024: $938m) (Note 3). The Group's EBITDA includes $2,125m (2024: $2,150m) of costs that are not allocated to segments. The costs are primarily attributable to centralised activities being R&D and general and administration. 97 CSL Limited Annual Report 2024/25
RkJQdWJsaXNoZXIy MjE2NDg3